Our mission is to deliver on the promise of precision medicine through targeted radiation. We exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. We are committed to refining the use of radiation in cancer care from diagnostics and staging, to therapy and surgical intervention.
We understand the importance of integrating sustainability into all that we do in the delivery of our purpose and mission. We continue to build on an internal culture that is driven by: ethics and values; patient outcomes, including access to medicines; the health, safety and wellbeing of our employees; and improving environmental performance. We aim for continued improvement across the spectrum of sustainability measures. Among other desirable outcomes, each is important in managing Group risk and opportunity, and improving financial and operating performance.
Our sustainability strategy centres on five pillars - our 'Five Ps': Purpose. People. Principles. Performance. Planet.
When we published our first Sustainability report in February 2022, we provided a clear roadmap for our sustainability journey. This 2023 report describes how we have progressed on this journey to improve our performance across our five sustainability pillars.
Our sustainability journey
